Better Than Bitcoin? (Top Crypto for Less Than $1)
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Warren Buffett's 2005 Warning Echoes Louder As Social Security Faces $18,100 Benefit Cut By 2033, CRFB Warns
Social Security faces dire future if Congress doesn't act. Analysis warns of 24% cuts in 7 years and insolvency for Medicare. Warren Buffett raised concerns 20 years ago.
Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way
New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
What we know about a new health data tracking system being announced by White House
WASHINGTON (AP) — President Donald Trump's planned announcement Wednesday of a that would make it easier for patients to access their health records and monitor their wellness is raising a host of privacy concerns.
Parents of man who died in Colorado jail say nurses, deputies ignored his pleas for 15 hours
DENVER (AP) — The parents of a man who died alone in a Colorado jail cell after an ulcer burned a hole in his digestive tract and left him in what they said was excruciating pain for about 15 hours filed a federal lawsuit Monday, accusing the jail's nurses and sheriff's deputes of ignoring his cries for help.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis Precision Medicines stock fluctuated after reporting mixed results for their drug vormatrigine in treating focal onset seizures.
The $100 Trillion AI Story No One Is Telling You - Ad
Jeff Brown recently traveled to a ghost town in the middle of an American desert... To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom... And only one company here in the U.S. can mine this obscure metal.
Bill Gates Highlights Ugandan Nurse Climbing 1000-Foot Ladders To Deliver Vaccines
Agnes Nambozo, a Ugandan nurse climbs 1,000-foot ladders daily to vaccinate children in remote mountains, said Bill Gates in his blog.
Debt and delayed care forecast for some who lose insurance under tax and spending law
Delayed treatments, canceled doctor visits, skipped prescriptions. Losing insurance is bad for your health.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Anavex Life Sciences: Early Blarcamesine Treatment Cuts Alzheimer's Progression by 20 Months
Anavex reported that early use of blarcamesine in Alzheimer's trials led to sustained cognitive and functional improvements over 4 years.
Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy
Teva raised 2025 guidance for Austedo, Ajovy, and Uzedy after Q2 earnings beat estimates, despite missing revenue expectations.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
UnitedHealth Hit By $6.5 Billion Medical Cost Blowout: Launches AI-Led Overhaul, Drops 600K Members To Regain Margins — 'These Are Serious Challenges'
Healthcare company, UnitedHealth Group Inc. (NYSE: UNH), says that it will drop 600,000 Medicare Advantage members and launch a sweeping operational overhaul after being blindsided by $6.5 billion in unanticipated medical costs.
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and broad patient impact.
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Sarepta will resume gene therapy shipments after FDA review of recent patient death
WASHINGTON (AP) — Shares of beleaguered drugmaker jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a .
Sarepta Therapeutics Stock Soars After FDA Removes Hold On Elevidys For Some Patients
Sarepta Therapeutics shares are halted in extended trading Monday after the U.S. Food and Drug Administration (FDA) recommended the removal of a voluntary hold for Elevidys.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
EU regulator approves injectable HIV drug that experts say could help stop transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
Meta launches new teen safety features, removes 635,000 accounts that sexualize children
Instagram parent company Meta has introduced new safety features aimed at protecting teens who use its platforms, including information about accounts that message them and an option to block and report accounts with one tap.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Teens say they are turning to AI for advice, friendship and 'to get out of thinking'
No question is too small when Kayla Chege, a high school student in Kansas, is using .
Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks
Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid operating margins.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
FDA names former pharmaceutical company executive to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the latest in a string of leadership changes at the agency.
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
WASHINGTON (AP) — Drugmaker said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of receiving one of its treatments for muscular dystrophy.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Why Is MEI Pharma Stock Soaring On Friday?
MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the average volume of 29.8K, as per data from Benzinga Pro.
Trump says Coke will shift to cane sugar. But increasingly, shoppers want no sugar in their sodas
The debate over whether should use high-fructose corn syrup or in its signature soda obscures an important fact: Consumers are increasingly looking for Coke with no sugar at all.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Republicans are considering changes to Trump's request for $9.4 billion in spending cuts
WASHINGTON (AP) — Senate Republicans were exploring changes Tuesday to President Donald Trump's to cancel $9.4 billion in previously approved spending targeted by his Department of Government Efficiency, signaling potential difficulties ahead of an important test vote.
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
Ultragenyx's UX111 gene therapy faces FDA delay due to facility issues; analysts adjust price targets amid uncertain resubmission timeline.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Beat the heat with these cooling gadgets and wearables
You can only sit in front of the fridge with the door open for so long.
Breakfast cereal sales declined for decades before Kellogg's sale to Italian company
Breakfast cereal could use a lucky charm.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.